UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
This article explains When To Use Total Return Index Rather Than Price Index, outlining scenarios where total return offers clearer insight.
28,063 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Bitmine Immersion Technologies slows weekly ETH purchases while maintaining a bullish stance. Tom Lee signals a forth...
Zcash climbs above $470 as investors react to news of the Ironwood upgrade slated for late July. The changes aim to m...
MBA data show a pullback in new home purchase applications in May as mortgage costs remained elevated. The trend unde...
Defi hacks turning high yields into a hidden tax are drawing fresh scrutiny, as Q2 losses from hacks totaled $780.3 m...
Aging homeowners are turning estate sales into a routine part of listings, prompting a need for a formal checklist re...
Across 2026, Ripple partnerships have yet to move XRP higher. The blockchain community watches a regulatory win for A...
Hecla Mining stock plunged from its peak as metal prices and costs shifted. This guide breaks down the key factors, w...
Large holders continue to add ADA as smaller investors trim positions, signaling a strategic shift even as sentiment ...
Dive into how to read myriad genetics (mygn) 2025 earnings transcripts, spot growth drivers, assess risk, and build a...
A surprising move in the stock market drew attention to Super Micro Computer. This article breaks down the forces beh...
In markets juggling record highs with recession fears, a few billionaire investors are doubling down on the backbone ...